Neurotech International (NTI) Stock Price, News & Analysis

Company Overview

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $45.85 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NTI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Neurotech International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neurotech International investors own include Standard Chartered (SCBFY), Advocate Rising Rate Hedge ETF (RRH), Defiance Next Gen H2 ETF (HDRO) and Cleveland-Cliffs (CLF).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: ASX:NTI
• CUSIP: N/A
• CIK: N/A
• Web: www.neurotechinternational.com
• Phone: 61 8 9389 3130
• Fax: N/A
• Employees: 7,134
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-5,070,000.00
• Net Margins: 15,972.18%
• Pretax Margin: N/A
• Return on Equity: -60.73%
• Return on Assets: -37.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 38.81
• Quick Ratio: 3.36

Sales & Book Value

• Annual Sales: $3.18 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,030,000,000
• Free Float: N/A
• Market Cap: $45.85 million
• Optionable: Not Optionable
• Beta: 1.46